Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
In this 42-minute educational video, Dr. Shonali Midha from Dana-Farber Cancer Institute explores the applications of CAR T-cell therapy and bispecific antibody therapy for patients with relapsed/refractory multiple myeloma. Discover the latest developments in immune-based treatment approaches for multiple myeloma, including clinical outcomes, patient selection criteria, and emerging therapeutic strategies. Gain valuable insights into how these innovative immunotherapies are transforming the treatment landscape for patients with this challenging hematologic malignancy.
